Physician profile
Lucy Burch
NPI 1184185167
$1,314.02
in general payments reported to CMS, 2019-2025
17 companies · $85.55 in 2025
The $85.55 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $424 · 2022: $275 · 2023: $232 · 2024: $298 · 2025: $85.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $387.44 | 2021-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $176.17 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $142.48 | 2022-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $124.64 | 2021-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.36 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $72.58 | 2021-2024 | |
| Amgen INC. | $55.14 | 2022-2023 | Repatha |
| Pfizer INC. | $43.26 | 2021-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $38.17 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $36.90 | 2021-2022 | |
| Novo Nordisk INC | $34.41 | 2024 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.46 | 2025 | Lifevest |
| Cardiva Medical, INC. | $26.13 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Edwards Lifesciences Corporation | $21.25 | 2025 | |
| Sanofi-Aventis U.S. LLC | $18.00 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $15.69 | 2024 | Nexletol |
| Philips North America LLC | $14.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Burch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.